Latest Fentanyl Stories
CUPERTINO, Calif., Dec. 16, 2014 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that it has entered into an agreement with Santen Pharmaceutical Co., Ltd.
DALLAS, December 11, 2014 /PRNewswire/ -- MarketReportsOnline.com adds "United States Anesthesia Drugs Market & Forecast", a 2014 industry research and data report
NEWARK, Calif., Nov. 20, 2014 /PRNewswire/ -- Depomed, Inc.
NEWARK, Calif., Nov. 12, 2014 /PRNewswire/ -- Depomed, Inc.
REDWOOD CITY, Calif., Nov. 10, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.
NEWARK, Calif., Oct. 27, 2014 /PRNewswire/ -- Depomed, Inc.
CUPERTINO, Calif., Oct. 27, 2014 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) reported today that Pfizer Inc. (NYSE: PFE) announced today that it has notified Pain Therapeutics, Inc.
Data from Sublingual Sufentanil Development Program Highlights Analgesic Response Compared to IV Morphine in Young vs Elderly Adult Patients REDWOOD CITY, Calif., Oct.
Entrenchment of Current Analgesics and Increasing Cost Sensitivity Will Hamper Uptake of Emerging Acute Pain Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass.,
- Growing in low tufty patches.